ICER releases draft evidence report on treatments for multiple sclerosis

ICER

17 October 2022 - Public comment period now open until 11 November 2022; requests to make oral comment during public meeting also being accepted.

The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of treatments for multiple sclerosis.

Read ICER announcement

Michael Wonder

Posted by:

Michael Wonder